
Szilard Kiss MD
Retinal Disease, Uveitis, Ocular Oncology
Director of Clinical Research, Associate Professor, Ophthalmology, Weill Cornell Medical College, New York/Presbyterian Hospital
1305 York Avenue11th FloorNew York, NY 10021
Overview of Dr. Kiss
Dr. Szilard Kiss is an ophthalmologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 24 years. Dr. Kiss accepts several types of health insurance, listed below. He is one of 275 doctors at New York-Presbyterian Hospital and one of 129 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Ophthalmology. He has more than 100 publications and over 500 citings.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2003 - 2006
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2002 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2002
Columbia College, Columbia UniversityB.A., 1993 - 1997
Certifications & Licensure
NY State Medical License 2008 - 2027
MA State Medical License 2006 - 2009
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
- Marquis Who's Who in America 2012
Clinical Trials
Publications & Presentations
PubMed
- Literature Review and Institutional Imaging Analysis of Ritonavir Retinal Toxicity.Carla G Dias, Tobin B T Thuma, Lili Gerendas, Joshua Seokju Kim, Jaffer Shah
Journal of Vitreoretinal Diseases. 2026-06-25 - MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.Elisah M Huynh, Mahmood Khan, Yanhan Ren, Anton Orlin, Szilard Kiss
Retinal Cases & Brief Reports. 2026-05-01 - Prevalence and spectrum of manifestations of tamoxifen retinopathy as assessed by multimodal and ultra-widefield retinal imaging.Ethan Zhao, Matthew Lin, Jennifer Marti, M Abdallah Mahrous, Anton Orlin
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2025-06-01
Journal Articles
- Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging with Ultrawide-Field Imaging for Determining Severity of Diabetic RetinopathyLee M Jampol, Lloyd Paul Aiello, Jennifer K Sun, Szilard Kiss, Charles C Wykoff, JAMA
- The Clinical Relevance of Visualising the Peripheral RetinaChristine Curcio, SriniVas R Sadda, Szilard Kiss, ScienceDirect
- Multimodal Retinal Imaging in the Era of Ocular Gene TherapyS Kiss, New Retina MD, 2/1/2014
Books/Book Chapters
Abstracts/Posters
- Profiling miRNAs in a hyperglycemic and hypoinsulinemic Ins2Akita mouse model.A Giocanti-Aurégan, L Ahn, SH Tsang, J Sancho-Pelluz, S Kiss, MI Rosenblatt, T Tuschl, JTG Pena, DJ. D’Amico, Annual Meeting of the Association of Research in Vision and Ophthalmology, Seattle, WA, 1/1/2013
- Symptomatic Posterior Vitreous Detachment: The predictive value of the posterior hyaloid face and symptomatology.C Falkner-Radler, DJ D’Amico, M Cho, A Orlin, RVP Chan, S Kiss, A Graf, S Binder, Annual Meeting of the Association of Research in Vision and Ophthalmology, Seattle, WA, 1/1/2013
- Unique Features of Choroidal Vasculature In Patients with Choroidal Neovascular Membranes.SD Bhaleeya, DJ D’Amico, S Kiss, Annual Meeting of the Association of Research in Vision and Ophthalmology, Seattle, WA, 1/1/2013
Lectures
- What’s New in the Treatment of Retinal Vein Occlusion, FacultyDetroit, MI - 5/10/2014
- Clinical Management of the Diabetic Patient in the New Healthcare Model – Integration of Ultra Widefield ImagingBoston, MA - 4/9/2014
- Intravitreal Steroids – Balancing Effective Use with Intraocular Pressure Control, FacultyBoston, MA - 4/8/2014
Press Mentions
CLINICAL TRIAL DOWNLOAD: Interim Data on Gene Therapy for Wet AMDNovember 1st, 2019
Gene Therapy Effective for Treating Macular Degeneration: StudyOctober 14th, 2019
Adverum Biotechnologies to Present 30-Month Preclinical Safety and Expression Data for ADVM-022 Gene Therapy in Wet AMD at the ASGCT 22nd Annual MeetingMay 2nd, 2019
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOGHI PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









